Floatz logo

Namenda

Mild Traumatic Brain Injury

Mansoura UniversityPhase 2/3Active
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
89/ 100

Competitive context

92 Active assets in the Mild Traumatic Brain Injury cohort.

Asset / SponsorPhaseRating
MELATONIN
Children's National Research Institute
Phase 4BBB
Valproic Acid
Northwestern University
Phase 4BBB
PROPRANOLOL
Tanta University
Phase 4BBB
NEPENTHE
Henry M. Jackson Foundation for the Advancement of Military Medicine
Phase 4BB
N-Acetyl-L-Cysteine
HonorHealth Research Institute
Phase 2BB

View all 50 →

Same molecule, other indications

Namenda is also rated in:

Alzheimer diseaseDormant
BBB
Indicative ·
74 / 100
View asset →
Lewy body dementiaDormant
BBB
Indicative ·
72 / 100
View asset →
dementiaDormant
BB
Indicative ·
70 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →